781 results on '"Møller, Jacob Eifer"'
Search Results
2. Acute kidney injury after out-of-hospital cardiac arrest
3. Heart Failure with Preserved vs. Reduced Ejection Fraction: Patient Characteristics, In-hospital Treatment and Mortality—DanAHF, a Nationwide Prospective Study
4. Future for cardiogenic shock research
5. Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: Determinants and relationship with patient-reported health status
6. Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis
7. Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program
8. Health-related quality of life and cognitive function after out-of-hospital cardiac arrest; a comparison of prehospital return-of-spontaneous circulation and refractory arrest managed with extracorporeal cardiopulmonary resuscitation
9. NatIonal Danish endocarditis stUdieS – Design and objectives of the NIDUS registry
10. Survival and neurological outcome after bystander versus lay responder defibrillation in out-of-hospital cardiac arrest: A sub-study of the BOX trial
11. DIFFERENCES IN MANAGEMENT AND PROGNOSTICATION OF CARDIOGENIC SHOCK PATIENTS IN THE PRESENCE AND ABSENCE OF OUT-OF-HOSPITAL CARDIAC ARREST
12. Dobutamine Stress Echocardiography in Low-Gradient Aortic Stenosis
13. Treatment effects of blood pressure targets and hemodynamics according to initial blood lactate levels in comatose out-of-hospital cardiac arrest patients – A sub study of the BOX trial
14. Psychometric Properties of the Kansas City Cardiomyopathy Questionnaire in a Surgical Population of Patients With Aortic Valve Stenosis
15. Quantitative pupillometry for neuroprognostication in comatose post-cardiac arrest patients: A protocol for a predefined sub-study of the Blood pressure and Oxygenations Targets after Out-of-Hospital Cardiac Arrest (BOX)-trial
16. Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study
17. Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest
18. Specific thresholds of quantitative pupillometry parameters predict unfavorable outcome in comatose survivors early after cardiac arrest
19. Danish-German cardiogenic shock trial—DanGer shock: Trial design update
20. Usefulness of aortic valve calcification in patients with low flow aortic stenosis
21. First-In-Man Trial of β3-Adrenoceptor Agonist Treatment in Chronic Heart Failure: Impact on Diastolic Function
22. The effect of empagliflozin on contractile reserve in heart failure: Prespecified sub-study of a randomized, double-blind, and placebo-controlled trial
23. The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker)
24. The association between self-reported health status and adverse events : a comparison among coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI)
25. at onal anish endocarditis st die – Design and objectives of the NIDUS registry
26. Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure
27. Transesophageal and intracardiac echocardiography to guide transcatheter tricuspid valve repair with the TriClip™ system
28. What to expect after open heart valve surgery? Changes in health-related quality of life
29. Does diabetes modify the effect of heparin on plasma proteins? - A proteomic search for plasma protein biomarkers for diabetes-related endothelial dysfunction
30. Use and coverage of automated external defibrillators according to location in out-of-hospital cardiac arrest
31. Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial
32. Empagliflozin to elderly and obese patients with increased risk of developing heart failure:Study protocol for the Empire Prevent trial program
33. Return to Work After Refractory Out-of-Hospital Cardiac Arrest in Patients Managed With or Without Extracorporeal Cardiopulmonary Resuscitation:A Nationwide Register-Based Study
34. Lactate and lactate clearance as predictors of one-year survival in extracorporeal cardiopulmonary resuscitation – An international, multicentre cohort study
35. Heart Failure with Preserved vs. Reduced Ejection Fraction:Patient Characteristics, In-hospital Treatment and Mortality —DanAHF, a Nationwide Prospective Study
36. Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
37. The association between aortic valve calcification, cardiovascular risk factors, and cardiac size and function in a general population
38. Microaxial flow pump (Impella CP®) in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.
39. Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery
40. Timing and treatment strategies according to SCAI classification in cardiogenic shock
41. DIFFERENCES IN MANAGEMENT AND PROGNOSTICATION OF CARDIOGENIC SHOCK PATIENTS IN THE PRESENCE AND ABSENCE OF OUT-OF-HOSPITAL CARDIAC ARREST
42. Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a Danish nationwide multicenter study
43. Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial
44. Sex Differences in Factors Associated With Progression of Aortic Valve Calcification in the General Population
45. Return to Work After Refractory Out-of-Hospital Cardiac Arrest in Patients Managed With or Without Extracorporeal Cardiopulmonary Resuscitation: A Nationwide Register-Based Study.
46. Contemporary Use of Temporary Mechanical Circulatory Support in Infarct Related Cardiogenic Shock. Time to stop and reflect?
47. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction
48. Sex differences in symptoms of anxiety, depression, post-traumatic stress disorder and cognitive function among survivors of Out-of-Hospital Cardiac Arrest
49. Measurement of left atrial volume by 2D and 3D non-contrast computed tomography compared with cardiac magnetic resonance imaging
50. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.